Three detailed articles discuss the role of immunotherapy in the treatment of advanced GI cancers.
This activity is intended for oncologists and gastroenterologists who treat patients with GI cancers.
The goal of this activity is to improve awareness of the latest data on the role of immunotherapy in gastrointestinal (GI) cancers.
Approximate Time to Complete: 1 hour
Course Available Beginning: Mar. 21, 2017
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge of the clinical trial data on immune checkpoint inhibitors in patients with advanced GI cancers
- Have greater knowledge of the potential impact of recent data on treatment for patients with advanced GI cancers